Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.4.23.B1 - napsin

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Acquired Immunodeficiency Syndrome
Immunostaining for thyroid transcription factor 1, Napsin A, p40, and cytokeratin 5 aids in differential diagnosis of non-small cell lung carcinoma.
Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas.
Acrospiroma
The utility of using immunohistochemistry in the differentiation of metastatic, cutaneous clear cell renal cell carcinoma and clear cell hidradenoma.
Adenocarcinoma
A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
A study of immunohistochemical differential expression in pulmonary and mammary carcinomas.
Aberrant expression of napsin A in a subset of malignant lymphomas.
Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer.
ALK and ROS1 rearrangements, coexistence and treatment in epidermal growth factor receptor-wild type lung adenocarcinoma: a multicenter study of 732 cases.
Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update.
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.
Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Close relation of large cell carcinoma to adenocarcinoma by hierarchical cluster analysis: implications for histologic typing of lung cancer on biopsies.
Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure.
Combination of Napsin A and TTF-1 Immunohistochemistry Helps in Differentiating Primary Lung Adenocarcinoma From Metastatic Carcinoma in the Lung.
Comparative Characteristics of Napsin A, TTF 1 and EGFR Mutation Expression in Mucinous Lung Cell Carcinomas.
Comparison of monoclonal napsin A, polyclonal napsin A, and TTF-1 for determining lung origin in metastatic adenocarcinomas.
Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes.
Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.
Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
Histopathological Spectrum and Immunohistochemical Profile of Lung Carcinomas: A 9-Year Study from a Tertiary Hospital in North India.
Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review.
Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma--sensitivity of TTF-1 is superior to napsin.
Immunostaining for thyroid transcription factor 1, Napsin A, p40, and cytokeratin 5 aids in differential diagnosis of non-small cell lung carcinoma.
IMP3 can predict aggressive behaviour of lung adenocarcinoma.
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis.
KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas.
Lung cancer histologic and immunohistochemical heterogeneity in the era of molecular therapies: analysis of 172 consecutive surgically resected, entirely sampled pulmonary carcinomas.
Maintenance therapy for advanced lung cancer: who, what, and when?
Malignant mesothelioma: A histomorphological and immunohistochemical study of 24 cases from a tertiary care hospital in Southern India.
Mesothelioma with signet-ring cell features: report of 23 cases.
Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer.
Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
Napsin A Expression in Human Tumors and Normal Tissues.
Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study.
Napsin A expression in small cell carcinoma of the lung: a cytologic study with review of differentials.
Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors.
Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin.
Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung.
Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs.
Napsin-A, A Possible Diagnostic Marker for Differentiating Clear Cell Ovarian Carcinoma From Other High-grade Ovarian Carcinomas.
Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
New immunohistochemical markers in the differential diagnosisof nonsmall cell lung carcinoma.
Newly available antibodies with practical applications in surgical pathology.
Non-sarcomatous spindle cell morphology in conventional lung adenocarcinoma: a clinicopathological study.
Novel gene mutations in well-differentiated fetal adenocarcinoma of the lung in the next generation sequencing era.
Occult carcinoma confirmed to be a diffuse sclerosing variant of papillary thyroid carcinoma with unusual immunohistochemical features: A pitfall of clinicopathological diagnosis.
PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis.
Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
Primary Vaginal Gastric-type Adenocarcinoma and Vaginal Adenosis Exhibiting Gastric Differentiation: Report of a Series With Detailed Immunohistochemical Analysis.
Pten and Dicer1 loss in the mouse uterus causes poorly differentiated endometrial adenocarcinoma.
Pulmonary adenocarcinomas with enteric differentiation: histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas.
Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases.
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Pulmonary-type adenocarcinoma and signet ring mucinous adenocarcinoma arising in an ovarian dermoid cyst: report of a unique case.
Rapid Multiplex Immunohistochemistry Using the 4-antibody Cocktail YANA-4 in Differentiating Primary Adenocarcinoma From Squamous Cell Carcinoma of the Lung.
Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
Role of Napsin A and Survivin Immunohistochemical Expression in Bronchogenic Adenocarcinoma.
S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells.
The application and diagnostic utility of immunocytochemistry on direct smears in the diagnosis of pulmonary adenocarcinoma and squamous cell carcinoma.
The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D.
The use of placental S100 (S100P), GATA3 and napsin A in the differential diagnosis of primary adenocarcinoma of the bladder and bladder metastasis from adenocarcinoma of the lung.
The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung.
Thyroid transcription factor 1 and Napsin A double stain: utilizing different vendor antibodies for diagnosing lung adenocarcinoma.
TTF-1 and napsin A do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas: proposal of a novel staining panel.
TTF-1 and Napsin-A Are Not Markers for Biliary Phenotype: An Immunohistochemical Study of Gallbladder Adenocarcinomas.
TTF-1, napsin A and CDX2 co-expression in metastatic rectal adenocarcinoma to the lung.
Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases.
Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion.
Utility of TTF-1 and Napsin-A in the work-up of malignant effusions.
Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.
Value of napsin A and thyroid transcription factor-1 in the identification of primary lung adenocarcinoma.
Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
[A Case of Lung Metastasis Occurring Four Years after Pancreaticoduodenectomy for Pancreatic Cancer].
[A case of resectable lung metastasis one year six months after surgery for pancreatic cancer].
[Combined detection of thyroid transcription factor 1 and napsin A in pleural fluid cell blocks facilitates cytopathologic diagnosis of pulmonary adenocarcinoma].
[Diagnosis value of TTF-1, Napsin A and Ki-67 index in primary salivary gland-type lung carcinomas].
[Prostate Carcinoma Mimics Lung Carcinoma: A Case Report].
[Two synchronous malignancies in a single nephrectomy specimen].
Adenocarcinoma of Lung
A study on the immunohistochemical expression of napsin A in oral squamous cell carcinomas, intraepithelial neoplasia, and normal oral mucosa.
A word of caution regarding napsin a expression in squamous cell carcinomas of the lung.
Adenocarcinoma of the Lung Metastatic to the Ovary With a Signet Ring Cell Component.
ALK-positive adenocarcinoma of the lung expressing neuroendocrine markers and presenting as a "pituitary adenoma".
An ALK-positive lung adenocarcinoma with gastric and skin metastasis: a case report and literature review.
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.
Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Case Report: Next-Generation Sequencing Reveals Tumor Origin in a Female Patient With Brain Metastases.
CDX-2 Expression in Primary Lung Adenocarcinoma.
Chromogenic immunohistochemical quadruplex provides accurate diagnostic differentiation of non-small cell lung cancer.
Clinicopathological and Prognostic Significance of the EML4-ALK Translocation and IGFR1, TTF1, Napsin A Expression in Patients with Lung Adenocarcinoma.
Combination of Napsin A and TTF-1 Immunohistochemistry Helps in Differentiating Primary Lung Adenocarcinoma From Metastatic Carcinoma in the Lung.
Comparison of monoclonal napsin A, polyclonal napsin A, and TTF-1 for determining lung origin in metastatic adenocarcinomas.
Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.
EGFR Mutated Lung Adenocarcinoma Metastasis to the Pancreas Mimicking Primary Pancreatic Ductal Carcinoma.
Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
Folate Receptor ? Expression Level Correlates With Histologic Grade in Lung Adenocarcinoma.
Human tissue distribution of TA02, which is homologous with a new type of aspartic proteinase, napsin A.
Immunoexpression of napsin A in renal neoplasms.
Immunohistochemical analysis and comparison of napsin A, TTF1, SPA and CK7 expression in primary lung adenocarcinoma.
Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
IMP3 can predict aggressive behaviour of lung adenocarcinoma.
Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas.
Intracranial Meningioma as Initial Clinical Manifestation of Occult Lung Carcinoma: Case Report.
KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas.
Lepidic and micropapillary growth pattern and expression of Napsin A can stratify patients of stage I lung adenocarcinoma into different prognostic subgroup.
Leukoerythroblastosis with Cytopenia as an Initial Presentation of Lung Adenocarcinoma.
Mesothelioma with signet-ring cell features: report of 23 cases.
MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung.
Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma.
Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.
Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
Napsin A expression in lung and kidney neoplasia: a review and update.
Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors.
Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung.
Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs.
Napsin A levels in epithelial lining fluid as a diagnostic biomarker of primary lung adenocarcinoma.
Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas.
Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray.
p40: a p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63.
Pepstatin pull-down at high pH is a powerful tool for detection and analysis of napsin A.
Poorly differentiated adenocarcinoma of an unknown primary with a thyroid tumour and an aggressive course: thyroid or lung carcinoma?
Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations.
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
Role of Napsin A and Survivin Immunohistochemical Expression in Bronchogenic Adenocarcinoma.
Role of Napsin A and TTF1 as a diagnostic marker for lung adenocarcinoma.
SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung Adenocarcinoma.
Surgical treatment of bone metastasis followed by a primary lung cancer lesion: report of a case.
The application of immunocytochemistry to direct smears in the diagnosis of effusions.
The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity.
The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment.
The high diagnostic accuracy of combined test of thyroid transcription factor 1 and Napsin A to distinguish between lung adenocarcinoma and squamous cell carcinoma: a meta-analysis.
The use of placental S100 (S100P), GATA3 and napsin A in the differential diagnosis of primary adenocarcinoma of the bladder and bladder metastasis from adenocarcinoma of the lung.
The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia.
Thyroid transcription factor 1 and Napsin A double stain: utilizing different vendor antibodies for diagnosing lung adenocarcinoma.
Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid.
TTF-1 and napsin A do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas: proposal of a novel staining panel.
TTF-1 and Napsin A double stain: A useful marker for diagnosing lung adenocarcinoma on fine-needle aspiration cell blocks.
TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions.
Tumor-to-tumor metastasis from lung cancer: a clinicopathological postmortem study.
Update on Immunohistochemical Analysis in Breast Lesions.
Value of napsin A and thyroid transcription factor-1 in the identification of primary lung adenocarcinoma.
[Clinicopathological and Prognostic Significance of a Panel of Tumor Biomarkers ?in Lung Adenocarcinoma: a Tissue Microarray Study].
Adenocarcinoma, Bronchiolo-Alveolar
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study.
Adenocarcinoma, Clear Cell
Napsin A Expression in Human Tumors and Normal Tissues.
Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Adenocarcinoma, Mucinous
Comparative Characteristics of Napsin A, TTF 1 and EGFR Mutation Expression in Mucinous Lung Cell Carcinomas.
Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma.
Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study.
Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
Nonspecific Reactivity of Polyclonal Napsin A Antibody in Mucinous Adenocarcinomas of Various Sites: A Word of Caution.
Adenofibroma
Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Recurrent NAB2-STAT6 gene fusions and oestrogen receptor-? expression in pulmonary adenofibromas.
Adenoma
Epithelial and organ-related marker expression in pituitary adenomas.
Immunoexpression of napsin A in renal neoplasms.
Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors.
Adenoma, Oxyphilic
Immunoexpression of napsin A in renal neoplasms.
Breast Neoplasms
A study of immunohistochemical differential expression in pulmonary and mammary carcinomas.
Aberrant Expression of Napsin A in Breast Carcinoma With Apocrine Features.
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Update on Immunohistochemical Analysis in Breast Lesions.
Carcinoid Tumor
Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors.
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Carcinoma
A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
A study of immunohistochemical differential expression in pulmonary and mammary carcinomas.
A study on the immunohistochemical expression of napsin A in oral squamous cell carcinomas, intraepithelial neoplasia, and normal oral mucosa.
A word of caution regarding napsin a expression in squamous cell carcinomas of the lung.
Aberrant expression of napsin A in a subset of malignant lymphomas.
Aberrant Expression of Napsin A in Breast Carcinoma With Apocrine Features.
Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer.
Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update.
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.
Calibration and Optimization of p53, WT1, and Napsin A Immunohistochemistry Ancillary Tests for Histotyping of Ovarian Carcinoma: Canadian Immunohistochemistry Quality Control (CIQC) Experience.
Can We Tell the Site of Origin of Metastatic Squamous Cell Carcinoma? An Immunohistochemical Tissue Microarray Study of 194 Cases.
Chromogenic immunohistochemical quadruplex provides accurate diagnostic differentiation of non-small cell lung cancer.
Clear Cell Renal Cell Carcinoma Metastatic to the Gynecologic Tract: A Clinicopathologic Analysis of 17 Cases.
Close relation of large cell carcinoma to adenocarcinoma by hierarchical cluster analysis: implications for histologic typing of lung cancer on biopsies.
Combination of Napsin A and TTF-1 Immunohistochemistry Helps in Differentiating Primary Lung Adenocarcinoma From Metastatic Carcinoma in the Lung.
Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours.
Comparative Characteristics of Napsin A, TTF 1 and EGFR Mutation Expression in Mucinous Lung Cell Carcinomas.
Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas.
Comparison of monoclonal napsin A, polyclonal napsin A, and TTF-1 for determining lung origin in metastatic adenocarcinomas.
Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes.
Despite Diagnostic Morphology, Many Mixed Endometrial Carcinomas Show Unexpected Immunohistochemical Staining Patterns.
Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
Diagnostic and Prognostic Role of Immunohistochemical Expression of Napsin-A Aspartic Peptidase in Clear Cell and Papillary Renal Cell Carcinoma: A Study Including 233 Primary and Metastatic Cases.
Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1?) and napsin A for diagnosing ovarian clear cell carcinoma.
Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.
Endometrial clear cell carcinoma invading the right oviduct with a cooccurring ipsilateral oviduct adenomatoid tumor: A case report.
Endometrial Tumor Classification by Histomorphology and Biomarkers in the Nurses' Health Study.
Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors.
Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
Fine-needle aspiration cytology of non-small cell lung carcinoma: A paradigm shift.
Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility.
Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis.
High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
Histopathological Spectrum and Immunohistochemical Profile of Lung Carcinomas: A 9-Year Study from a Tertiary Hospital in North India.
Immunoexpression of napsin A in renal neoplasms.
Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma--sensitivity of TTF-1 is superior to napsin.
Immunostaining for thyroid transcription factor 1, Napsin A, p40, and cytokeratin 5 aids in differential diagnosis of non-small cell lung carcinoma.
Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas.
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis.
Lung cancer histologic and immunohistochemical heterogeneity in the era of molecular therapies: analysis of 172 consecutive surgically resected, entirely sampled pulmonary carcinomas.
Mesothelioma with signet-ring cell features: report of 23 cases.
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Napsin A as a marker of clear cell ovarian carcinoma.
Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
Napsin A Expression in Human Tumors and Normal Tissues.
Napsin A expression in lung and kidney neoplasia: a review and update.
Napsin A expression in small cell carcinoma of the lung: a cytologic study with review of differentials.
Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors.
Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs.
Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray.
Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
Napsin A: Another milestone in the subclassification of ovarian carcinoma.
Napsin-A and AMACR are Superior to HNF-1? in Distinguishing Between Mesonephric Carcinomas and Clear Cell Carcinomas of the Gynecologic Tract.
Napsin-A Expression, a Reliable Immunohistochemical Marker for Diagnosis of Ovarian and Endometrial Clear Cell Carcinomas.
Napsin-A, A Possible Diagnostic Marker for Differentiating Clear Cell Ovarian Carcinoma From Other High-grade Ovarian Carcinomas.
New immunohistochemical markers in the differential diagnosisof nonsmall cell lung carcinoma.
Numerous osteoclast-like giant cells in metastases from lung adenocarcinoma, but absent from primary tumor.
Occult ovarian clear-cell carcinoma diagnosed as primary adenocarcinoma of the lung: A case report of a diagnostic pitfall for clinicians and pathologists.
Ovarian Carcinoma Histotype: Strengths and Limitations of Integrating Morphology With Immunohistochemical Predictions.
p40: a p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63.
Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma.
PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis.
Pepstatin pull-down at high pH is a powerful tool for detection and analysis of napsin A.
Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Raspberry bodies and hyaline globules with positive napsin A immunoexpression are useful features in diagnosing clear cell carcinoma of the female genital tract in cytology samples.
Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA, Syn and Napsin A.
Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
Should endometrial clear cell carcinoma be classified as Type II endometrial carcinoma?
Small-cell lung cancer transformation from EGFR-mutant adenocarcinoma after EGFR-TKIs resistance: A case report.
Spindle cell and pleomorphic ("sarcomatoid") carcinomas of the lung: an immunohistochemical analysis of 86 cases.
Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
Surfactant Protein A and Napsin A in the Immunohistochemical Characterization of Canine Pulmonary Carcinomas: Comparison With Thyroid Transcription Factor-1.
The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity.
The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes.
The high diagnostic accuracy of combined test of thyroid transcription factor 1 and Napsin A to distinguish between lung adenocarcinoma and squamous cell carcinoma: a meta-analysis.
The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary.
The role of Napsin-A and Desmocollin-3 in classifying poorly differentiating non-small cell lung carcinoma.
The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung.
Tumor-to-tumor metastasis from lung cancer: a clinicopathological postmortem study.
Unusual expression of thyroid transcription factor 1 and napsin a in metastatic adenoid cystic carcinoma of extrapulmonary origin in the lung.
Use of Immunohistochemical Markers (HNF-1?, Napsin A, ER, CTH, and ASS1) to Distinguish Endometrial Clear Cell Carcinoma From Its Morphologic Mimics Including Arias-Stella Reaction.
Utility of a Novel Triple Marker (Combination of TTF-1, Napsin-A and P40) in the Subclassification of Non-Small Cell Lung Carcinomas using Fine Needle Aspiration Cases.
Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases.
Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma.
Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
[Clinicopathologic features and genetic profile of the redefined large cell lung carcinoma].
[Diagnosis value of TTF-1, Napsin A and Ki-67 index in primary salivary gland-type lung carcinomas].
[Diagnostic and prognostic implications of MAML2 gene translocation in primary pulmonary mucoepidermoid carcinoma].
[Diagnostic value of combined detection of HNF-1? and Napsin A in the diagnosis of ovarian clear cell carcinoma].
[Prostate Carcinoma Mimics Lung Carcinoma: A Case Report].
Carcinoma, Adenoid Cystic
Unusual expression of thyroid transcription factor 1 and napsin a in metastatic adenoid cystic carcinoma of extrapulmonary origin in the lung.
Carcinoma, Adenosquamous
[Diagnosis value of TTF-1, Napsin A and Ki-67 index in primary salivary gland-type lung carcinomas].
Carcinoma, Bronchogenic
Role of Napsin A and Survivin Immunohistochemical Expression in Bronchogenic Adenocarcinoma.
Carcinoma, Endometrioid
Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours.
Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas.
Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1?) and napsin A for diagnosing ovarian clear cell carcinoma.
Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility.
Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas.
Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
[Diagnostic value of combined detection of HNF-1? and Napsin A in the diagnosis of ovarian clear cell carcinoma].
Carcinoma, Hepatocellular
Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature.
Carcinoma, Large Cell
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.
Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA, Syn and Napsin A.
Carcinoma, Neuroendocrine
Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors.
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA, Syn and Napsin A.
Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 cases.
Carcinoma, Non-Small-Cell Lung
?Np63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens.
Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
Immunostaining for thyroid transcription factor 1, Napsin A, p40, and cytokeratin 5 aids in differential diagnosis of non-small cell lung carcinoma.
Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
New immunohistochemical markers in the differential diagnosisof nonsmall cell lung carcinoma.
Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
The role of Napsin-A and Desmocollin-3 in classifying poorly differentiating non-small cell lung carcinoma.
The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer.
Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
[Histologic subtyping of poorly-differentiated solid lung cancer with molecular testing for epidermal growth factor receptor mutation and ALK gene rearrangement: an analyses of 167 cases].
Carcinoma, Ovarian Epithelial
Napsin-A, A Possible Diagnostic Marker for Differentiating Clear Cell Ovarian Carcinoma From Other High-grade Ovarian Carcinomas.
Carcinoma, Papillary
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
Carcinoma, Renal Cell
A study on the immunohistochemical expression of napsin A in oral squamous cell carcinomas, intraepithelial neoplasia, and normal oral mucosa.
Aberrant expression of napsin A in a subset of malignant lymphomas.
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.
Clear Cell Renal Cell Carcinoma Metastatic to the Gynecologic Tract: A Clinicopathologic Analysis of 17 Cases.
Combination of Napsin A and TTF-1 Immunohistochemistry Helps in Differentiating Primary Lung Adenocarcinoma From Metastatic Carcinoma in the Lung.
Diagnostic and Prognostic Role of Immunohistochemical Expression of Napsin-A Aspartic Peptidase in Clear Cell and Papillary Renal Cell Carcinoma: A Study Including 233 Primary and Metastatic Cases.
Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Immunoexpression of napsin A in renal neoplasms.
Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
Napsin A Expression in Human Tumors and Normal Tissues.
Napsin A expression in lung and kidney neoplasia: a review and update.
Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma.
The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity.
The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
Tumor-to-tumor metastasis from lung cancer: a clinicopathological postmortem study.
Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma.
Carcinoma, Small Cell
Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors.
Napsin A expression in small cell carcinoma of the lung: a cytologic study with review of differentials.
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Small-cell lung cancer transformation from EGFR-mutant adenocarcinoma after EGFR-TKIs resistance: A case report.
The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
Carcinoma, Squamous Cell
A comprehensive immunohistochemistry algorithm for the histological subtyping of small biopsies obtained from non-small cell lung cancers.
A study on the immunohistochemical expression of napsin A in oral squamous cell carcinomas, intraepithelial neoplasia, and normal oral mucosa.
A word of caution regarding napsin a expression in squamous cell carcinomas of the lung.
Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancer.
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Can We Tell the Site of Origin of Metastatic Squamous Cell Carcinoma? An Immunohistochemical Tissue Microarray Study of 194 Cases.
Chromogenic immunohistochemical quadruplex provides accurate diagnostic differentiation of non-small cell lung cancer.
Close relation of large cell carcinoma to adenocarcinoma by hierarchical cluster analysis: implications for histologic typing of lung cancer on biopsies.
Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
Desmoglein-3 and Napsin A double stain, a useful immunohistochemical marker for differentiation of lung squamous cell carcinoma and adenocarcinoma from other subtypes.
Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.
Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis.
Immunostaining for thyroid transcription factor 1, Napsin A, p40, and cytokeratin 5 aids in differential diagnosis of non-small cell lung carcinoma.
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis.
Lung cancer histologic and immunohistochemical heterogeneity in the era of molecular therapies: analysis of 172 consecutive surgically resected, entirely sampled pulmonary carcinomas.
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
New immunohistochemical markers in the differential diagnosisof nonsmall cell lung carcinoma.
p40: a p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63.
PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis.
Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells.
The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
The high diagnostic accuracy of combined test of thyroid transcription factor 1 and Napsin A to distinguish between lung adenocarcinoma and squamous cell carcinoma: a meta-analysis.
The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung.
Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases.
Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
Carcinosarcoma
Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
Cerebellar Neoplasms
Napsin a and thyroid transcription factor-1-positive cerebellar tumor with epidermal growth factor receptor mutation.
Cholangiocarcinoma
TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels.
Colorectal Neoplasms
A case of napsin A-positive metastatic lung cancer originating from the colon.
Pulmonary adenocarcinomas with enteric differentiation: histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas.
Pulmonary enteric adenocarcinoma: a study of the clinicopathologic and molecular status of nine cases.
Confusion
Expression of Markers of Müllerian Clear Cell Carcinoma in Primary Cervical and Vaginal Gastric-type Adenocarcinomas.
Unexpected TTF-1 Positivity in a Subset of Gastric Adenocarcinomas.
Cystadenofibroma
Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Endodermal Sinus Tumor
Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours.
Endometrial tumors with yolk sac tumor-like morphologic patterns or immunophenotypes: an expanded appraisal.
High-level expression of divergent endodermal lineage markers in gonadal and extra-gonadal yolk sac tumors.
Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Endometrial Neoplasms
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas.
Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility.
Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas.
Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
Endometriosis
Abdominal Wall Clear Cell Carcinoma: Case Report of a Rare Event with Potential Diagnostic Difficulties.
Histiocytoma, Benign Fibrous
Napsin A is differentially expressed in sclerosing hemangiomas of the lung.
Idiopathic Pulmonary Fibrosis
The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D.
Kidney Diseases
The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D.
Kidney Neoplasms
Immunoexpression of napsin A in renal neoplasms.
Krukenberg Tumor
Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1?) and napsin A for diagnosing ovarian clear cell carcinoma.
[Diagnostic value of combined detection of HNF-1? and Napsin A in the diagnosis of ovarian clear cell carcinoma].
Lung Neoplasms
?Np63, CK5/6, TTF-1 and napsin A, a reliable panel to subtype non-small cell lung cancer in biopsy specimens.
A case of napsin A-positive metastatic lung cancer originating from the colon.
Automated Immunohistochemistry Assay for the Detection of Napsin-A in Formalin-Fixed Paraffin-Embedded Tissues from Lung Tumors.
Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors.
Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
Generation and evaluation of a monoclonal antibody, designated MAdL, as a new specific marker for adenocarcinomas of the lung.
Immunohistochemical analysis and comparison of napsin A, TTF1, SPA and CK7 expression in primary lung adenocarcinoma.
Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
IMP3 can predict aggressive behaviour of lung adenocarcinoma.
Metastatic lung adenocarcinoma to the kidney diagnosed by urine cytology: a case report.
Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer.
Napsin A is differentially expressed in sclerosing hemangiomas of the lung.
Napsin A is negatively associated with EMT?mediated EGFR?TKI resistance in lung cancer cells.
New immunohistochemical markers in the differential diagnosisof nonsmall cell lung carcinoma.
Occult ovarian clear-cell carcinoma diagnosed as primary adenocarcinoma of the lung: A case report of a diagnostic pitfall for clinicians and pathologists.
Overexpression of Napsin A resensitizes drug-resistant lung cancer A549 cells to gefitinib by inhibiting EMT.
Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
S100A7 promotes lung adenocarcinoma to squamous carcinoma transdifferentiation, and its expression is differentially regulated by the Hippo-YAP pathway in lung cancer cells.
Surfactant Protein A and Napsin A in the Immunohistochemical Characterization of Canine Pulmonary Carcinomas: Comparison With Thyroid Transcription Factor-1.
The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer.
Value of napsin A and thyroid transcription factor-1 in the identification of primary lung adenocarcinoma.
[A Case of Metastatic Small Intestinal Tumor Diagnosed with Intestinal Obstruction].
[Histologic subtyping of poorly-differentiated solid lung cancer with molecular testing for epidermal growth factor receptor mutation and ALK gene rearrangement: an analyses of 167 cases].
Lymphatic Metastasis
Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
Unexpected TTF-1 Positivity in a Subset of Gastric Adenocarcinomas.
Lymphoma
A rare case of primary peripheral epithelial myoepithelial carcinoma of lung: Case report and literature review.
Aberrant expression of napsin A in a subset of malignant lymphomas.
Immunohistochemical Profiling of ALK Fusion Gene-Positive Adenocarcinomas of the Lung.
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy.
Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
Prognostic analysis of primary mucin-producing adenocarcinoma of the lung: a comprehensive retrospective study.
The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia.
Lymphoma, B-Cell
Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
Lymphoma, Large B-Cell, Diffuse
Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
Mesothelioma
Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Malignant mesothelioma: A histomorphological and immunohistochemical study of 24 cases from a tertiary care hospital in Southern India.
Mesothelioma with signet-ring cell features: report of 23 cases.
Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma.
Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.
Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma.
Mesothelioma, Malignant
Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure.
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Neoplasm Metastasis
A case of napsin A-positive metastatic lung cancer originating from the colon.
A study of immunohistochemical differential expression in pulmonary and mammary carcinomas.
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.
Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Case Report: Next-Generation Sequencing Reveals Tumor Origin in a Female Patient With Brain Metastases.
EGFR Mutated Lung Adenocarcinoma Metastasis to the Pancreas Mimicking Primary Pancreatic Ductal Carcinoma.
Epithelial and organ-related marker expression in pituitary adenomas.
Gastric metastasis from primary lung adenocarcinoma mimicking primary gastric cancer.
Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
Initial clinical presentation of single soft tissue metastasis of medullary thyroid carcinoma without primary tumor in the thyroid gland.
Intracranial Meningioma as Initial Clinical Manifestation of Occult Lung Carcinoma: Case Report.
Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma.
Proteomic analysis of laser-microdissected paraffin-embedded tissues: (2) MRM assay for stage-related proteins upon non-metastatic lung adenocarcinoma.
Role of conventional immunomarkers, HNF4-? and SATB2, in the differential diagnosis of pulmonary and colorectal adenocarcinomas.
Solitary Lung Metastasis of Prostate Cancer with a Long Disease-Free Interval and Normal Prostate-Specific Antigen Level.
The use of placental S100 (S100P), GATA3 and napsin A in the differential diagnosis of primary adenocarcinoma of the bladder and bladder metastasis from adenocarcinoma of the lung.
Tumor-to-tumor metastasis from lung cancer: a clinicopathological postmortem study.
Unexpected TTF-1 Positivity in a Subset of Gastric Adenocarcinomas.
Value of napsin A and thyroid transcription factor-1 in the identification of primary lung adenocarcinoma.
[A Case of Lung Metastasis Occurring Four Years after Pancreaticoduodenectomy for Pancreatic Cancer].
[A case of resectable lung metastasis one year six months after surgery for pancreatic cancer].
Neoplasms
A case of napsin A-positive metastatic lung cancer originating from the colon.
A novel approach using sorafenib in alpha fetoprotein-producing hepatoid adenocarcinoma of the lung.
A Rare Case of GATA3 Positivity in Pleomorphic Lung Carcinoma in a Patient with History of Intracystic Papillary Carcinoma of the Breast: Primary Lung or Metastatic Disease?
A study on the immunohistochemical expression of napsin A in oral squamous cell carcinomas, intraepithelial neoplasia, and normal oral mucosa.
A word of caution regarding napsin a expression in squamous cell carcinomas of the lung.
Aberrant expression of napsin A in a subset of malignant lymphomas.
Aberrant Expression of Napsin A in Breast Carcinoma With Apocrine Features.
Adenocarcinoma of the thymus: mucinous subtype.
ALK Rearrangements Characterize 2 Distinct Types of Salivary Gland Carcinomas: Clinicopathologic and Molecular Analysis of 4 Cases and Literature Review.
ALK-positive adenocarcinoma of the lung expressing neuroendocrine markers and presenting as a "pituitary adenoma".
An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung.
Application of immunohistochemistry in the diagnosis of epithelioid mesothelioma: a review and update.
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma.
Atypical Proliferative (Borderline) Serous Tumor in the Brain: A Case Report.
Automated Immunohistochemistry Assay for the Detection of Napsin-A in Formalin-Fixed Paraffin-Embedded Tissues from Lung Tumors.
Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Calibration and Optimization of p53, WT1, and Napsin A Immunohistochemistry Ancillary Tests for Histotyping of Ovarian Carcinoma: Canadian Immunohistochemistry Quality Control (CIQC) Experience.
Case Report: Next-Generation Sequencing Reveals Tumor Origin in a Female Patient With Brain Metastases.
CDX-2 Expression in Primary Lung Adenocarcinoma.
Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours.
Comparative Use of Napsin A and Glypican 3 to Distinguish Endometrial Clear Cell from Serous and Endometrioid Carcinomas.
Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.
Concordant clear cell "mesonephric" carcinoma of the bladder and lung adenocarcinoma with clear cell features - multiple primaries versus metastatic neoplasms: a case report.
Cytopathologic features and differential diagnostic considerations of primary lymphoepithelioma-like carcinoma of the lung.
Cytopathologic findings and differential diagnostic considerations of primary clear cell carcinoma of the lung.
Despite Diagnostic Morphology, Many Mixed Endometrial Carcinomas Show Unexpected Immunohistochemical Staining Patterns.
Diagnostic and Prognostic Role of Immunohistochemical Expression of Napsin-A Aspartic Peptidase in Clear Cell and Papillary Renal Cell Carcinoma: A Study Including 233 Primary and Metastatic Cases.
Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1?) and napsin A for diagnosing ovarian clear cell carcinoma.
Difficulties of clinical and histopathological diagnosis in advanced vulvar clear cell carcinoma.
Effects of siRNA Silencing of TUG1 and LCAL6 Long Non-coding RNAs on Patient-derived Xenograft of Non-small Cell Lung Cancer.
Endometrial tumors with yolk sac tumor-like morphologic patterns or immunophenotypes: an expanded appraisal.
Epithelial and organ-related marker expression in pituitary adenomas.
Gastrointestinal hemorrhage caused by duodenal metastasis from a primary lung adenocarcinoma: A case report.
Glycoproteomic analysis of bronchoalveolar lavage (BAL) fluid identifies tumor-associated glycoproteins from lung adenocarcinoma.
Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis.
High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the "SET" feature of high-grade serous carcinoma to the "STEM" feature.
High-level expression of divergent endodermal lineage markers in gonadal and extra-gonadal yolk sac tumors.
Histopathologic, immunophenotypic and cytogenetic features of pulmonary mucoepidermoid carcinoma.
Hyalinizing clear cell carcinoma of the bronchial glands: presentation of three cases and pathological comparisons with salivary gland counterparts and bronchial mucoepidermoid carcinomas.
Hyalinizing Clear Cell Carcinoma of the Lung: Case Report and Review of the Literature.
Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review.
Immunoexpression of napsin A in renal neoplasms.
Immunohistochemical analysis and comparison of napsin A, TTF1, SPA and CK7 expression in primary lung adenocarcinoma.
Immunohistochemical Detection of Pax8 and Napsin A in Canine Thyroid Tumours: Comparison with Thyroglobulin, Calcitonin and Thyroid Transcription Factor 1.
Infrequent Immunohistochemical Expression of Napsin A in Endometrial Carcinomas.
Initial clinical presentation of single soft tissue metastasis of medullary thyroid carcinoma without primary tumor in the thyroid gland.
Ki-67 Index of 55% Distinguishes Two Groups of Bronchopulmonary Pure and Composite Large Cell Neuroendocrine Carcinomas with Distinct Prognosis.
Leptomeningeal carcinomatosis as initial presentation in adenocarcinoma of lung with signet ring cell features: an autopsy case report.
Lung metastasis from gastric cancer presenting as diffuse ground-glass opacities.
Lung recurrence and its therapeutic strategy in patients with pancreatic cancer.
Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups.
Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer.
Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Napsin a and thyroid transcription factor-1-positive cerebellar tumor with epidermal growth factor receptor mutation.
Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Napsin A as a marker of clear cell ovarian carcinoma.
Napsin A Expression in Anaplastic Lymphoma Kinase-positive Diffuse Large B-Cell Lymphoma: A Diagnostic Pitfall.
Napsin A Expression in Human Tumors and Normal Tissues.
Napsin A expression in lung and kidney neoplasia: a review and update.
Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study.
Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
Napsin A is a highly sensitive marker for nephrogenic adenoma: an immunohistochemical study with a specificity test in genitourinary tumors.
Napsin A is a specific marker for ovarian clear cell adenocarcinoma.
Napsin A is an independent prognostic factor in surgically resected adenocarcinoma of the lung.
Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
Napsin A staining in adrenal cortical neoplasms.
Napsin A, a member of the aspartic protease family, is abundantly expressed in normal lung and kidney tissue and is expressed in lung adenocarcinomas.
Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
Non-sarcomatous spindle cell morphology in conventional lung adenocarcinoma: a clinicopathological study.
Occult carcinoma confirmed to be a diffuse sclerosing variant of papillary thyroid carcinoma with unusual immunohistochemical features: A pitfall of clinicopathological diagnosis.
Occult ovarian clear-cell carcinoma diagnosed as primary adenocarcinoma of the lung: A case report of a diagnostic pitfall for clinicians and pathologists.
Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination.
Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma.
Pepstatin pull-down at high pH is a powerful tool for detection and analysis of napsin A.
Polyclonal napsin A expression: a potential diagnostic pitfall in distinguishing primary from metastatic mucinous tumors in the lung.
Primary pulmonary adenocarcinoma with enteric differentiation resembling metastatic colorectal carcinoma: A report of the second case negative for cytokeratin 7.
Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion, resembling extraskeletal myxoid chondrosarcoma: Case report with a review of Literature.
Primary Thymic Signet Ring Cell Adenocarcinoma: A Currently Unrecognized Variant.
Prognostic analysis of primary mucin-producing adenocarcinoma of the lung: a comprehensive retrospective study.
Prognostic implications of immunohistochemistry markers for EGFR-TKI therapy in Chinese patients with advanced lung adenocarcinoma harboring EGFR mutations.
Pulmonary Adenocarcinoma Mimicking Desquamative Interstitial Pneumonia: Report of 2 Cases With Genetic Analysis.
Pulmonary Adenocarcinoma, Intra-alveolar Variant: A Rare Entity Mimicking Desquamative Interstitial Pneumonia.
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
Role of Napsin A and Survivin Immunohistochemical Expression in Bronchogenic Adenocarcinoma.
ROS1-rearranged high-PD-L1-expressing lung adenocarcinoma manifesting as mediastinal tumor: A case report.
Sarcomatoid carcinoma in cytology: Report of a rare entity presenting in pleural and pericardial fluid preparations.
Solitary Lung Metastasis of Prostate Cancer with a Long Disease-Free Interval and Normal Prostate-Specific Antigen Level.
Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
Surfactant Protein A and Napsin A in the Immunohistochemical Characterization of Canine Pulmonary Carcinomas: Comparison With Thyroid Transcription Factor-1.
Surgical treatment of bone metastasis followed by a primary lung cancer lesion: report of a case.
The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity.
The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
Tissue-Preserving Antibody Cocktails to Differentiate Primary Squamous Cell Carcinoma, Adenocarcinoma, and Small Cell Carcinoma of Lung.
TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions.
TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels.
Unusual expression of thyroid transcription factor 1 and napsin a in metastatic adenoid cystic carcinoma of extrapulmonary origin in the lung.
Utility of a Novel Triple Marker (Combination of TTF-1, Napsin-A and P40) in the Subclassification of Non-Small Cell Lung Carcinomas using Fine Needle Aspiration Cases.
Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases.
Well-differentiated fetal adenocarcinoma of the lung: clinicopathologic features of 45 cases in China.
[A Case of Lung Metastasis Occurring Four Years after Pancreaticoduodenectomy for Pancreatic Cancer].
[A Case of Metastatic Small Intestinal Tumor Diagnosed with Intestinal Obstruction].
[Clear Cell Carcinoma of Cervix in a 12-Year-Old Girl: A Case Report].
[Clinicopathologic features and epidermal growth factor receptor gene mutation of primary pulmonary mucoepidermoid carcinoma].
[Diagnosis value of TTF-1, Napsin A and Ki-67 index in primary salivary gland-type lung carcinomas].
[Diagnostic value of combined detection of HNF-1? and Napsin A in the diagnosis of ovarian clear cell carcinoma].
[Fetal adenocarcinoma of the lung: a clinicopathologic analysis of six cases].
[Lung Metastasis of Breast Cancer Five Years after Mastectomy - A Case Report].
[Lung non-terminal respiratory unit type adenocarcinoma: a clinicopathologic study].
Neoplasms, Unknown Primary
The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
Neuroendocrine Tumors
Evaluation of napsin A, TTF-1, p63, p40, and CK5/6 immunohistochemical stains in pulmonary neuroendocrine tumors.
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 cases.
Ovarian Neoplasms
The lung-restricted marker napsin A is highly expressed in clear cell carcinomas of the ovary.
Pancreatic Neoplasms
[A Case of Lung Metastasis Occurring Four Years after Pancreaticoduodenectomy for Pancreatic Cancer].
[A case of resectable lung metastasis one year six months after surgery for pancreatic cancer].
Paraganglioma
Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 cases.
Pleural Effusion
Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review.
Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions.
TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions.
Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion.
Prostatic Neoplasms
Solitary Lung Metastasis of Prostate Cancer with a Long Disease-Free Interval and Normal Prostate-Specific Antigen Level.
Proteinuria
Immunohistochemical localization of napsin and its potential role in protein catabolism in renal proximal tubules.
Pulmonary Alveolar Proteinosis
Cathepsin H and napsin A are active in the alveoli and increased in alveolar proteinosis.
Pulmonary Fibrosis
[Effect of Napsin A transfection into type II alveolar epithelial cells on pulmonary fibrosis].
Sarcoma
Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology.
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy.
Small Cell Lung Carcinoma
IMP3 can predict aggressive behaviour of lung adenocarcinoma.
Squamous Cell Carcinoma of Head and Neck
A study on the immunohistochemical expression of napsin A in oral squamous cell carcinomas, intraepithelial neoplasia, and normal oral mucosa.
Thyroid Cancer, Papillary
Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
Napsin A Expression in Human Tumors and Normal Tissues.
Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
Occult carcinoma confirmed to be a diffuse sclerosing variant of papillary thyroid carcinoma with unusual immunohistochemical features: A pitfall of clinicopathological diagnosis.
Thyroid Neoplasms
Applications and Limitations of Immunohistochemical Expression of "Napsin-A" in Distinguishing Lung Adenocarcinoma From Adenocarcinomas of Other Organs.
Initial clinical presentation of single soft tissue metastasis of medullary thyroid carcinoma without primary tumor in the thyroid gland.
Napsin A expression in anaplastic, poorly differentiated, and micropapillary pattern thyroid carcinomas.
Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.
Occult carcinoma confirmed to be a diffuse sclerosing variant of papillary thyroid carcinoma with unusual immunohistochemical features: A pitfall of clinicopathological diagnosis.
Poorly differentiated adenocarcinoma of an unknown primary with a thyroid tumour and an aggressive course: thyroid or lung carcinoma?
The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
Wilms Tumor
Metastasis of Sarcomatoid Malignant Mesothelioma With p16/CDKN2A Deletion Manifested as a Subcutaneous Mass in the Back: A Case Report and Review of Literature.
Napsin-A, A Possible Diagnostic Marker for Differentiating Clear Cell Ovarian Carcinoma From Other High-grade Ovarian Carcinomas.
Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma.
Utility and pitfall of Immunohistochemistry in the Differential Diagnosis between Epithelioid Mesothelioma and Poorly Differentiated Lung Squamous Cell Carcinoma.
Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma.